Detalhe da pesquisa
1.
Optimally Choosing Medication Type for Patients With Opioid Use Disorder.
Am J Epidemiol
; 192(5): 748-756, 2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549900
2.
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial.
Ann Emerg Med
; 82(3): 272-287, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140493
3.
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial.
Am J Addict
; 32(3): 291-300, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645265
4.
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder.
Am J Addict
; 32(6): 584-592, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583120
5.
Moderation of buprenorphine therapy for cocaine dependence efficacy by variation of the Prodynorphin gene.
Eur J Clin Pharmacol
; 78(6): 965-973, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218405
6.
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD.
Addict Biol
; 27(2): e13112, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34877769
7.
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.
Subst Use Misuse
; 57(11): 1732-1742, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975917
8.
Association of substance use characteristics and future homelessness among emergency department patients with drug use or unhealthy alcohol use: Results from a linked data longitudinal cohort analysis.
Subst Abus
; 43(1): 1100-1109, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35499455
9.
Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial.
Alcohol Clin Exp Res
; 45(12): 2569-2578, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698397
10.
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.
Am J Addict
; 30(5): 433-444, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34075644
11.
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder.
Am J Addict
; 29(6): 536-542, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438502
12.
Clinical Trials for Opioid Use Disorder.
Handb Exp Pharmacol
; 258: 167-202, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31889218
13.
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.
Ann Intern Med
; 170(2): 90-98, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30557443
14.
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.
Am J Drug Alcohol Abuse
; 46(6): 761-768, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32851876
15.
Health-related material needs and substance use among emergency department patients.
Subst Abus
; 41(2): 196-202, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368863
16.
Misclassification of overdose events in the X:BOT study - Authors' reply.
Lancet
; 402(10401): 527-528, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480935
17.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lancet
; 391(10118): 309-318, 2018 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29150198
18.
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
N Engl J Med
; 374(13): 1232-42, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27028913
19.
Screening for Substance Use in Rural Primary Care: a Qualitative Study of Providers and Patients.
J Gen Intern Med
; 34(12): 2824-2832, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414355
20.
Rudolph et al. Respond to "Mathematization of Epidemiology".
Am J Epidemiol
; 192(5): 760-761, 2023 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36721371